Felipe Batalini, M.D.
Dr. Batalini is a physician-scientist focused on the treatment of breast and gynecological cancers. He completed his oncology training at BIDMC/Harvard Medical School and his postdoctoral training at the Broad Institute of Harvard and MIT. He is an Assistant Professor of Medicine and Co-Director of Genetics and Biochemistry for the Mayo Clinic Alix School of Medicine. In the lab, Dr. Batalini uses bioinformatics and genomics to identify biomarkers of response and mechanisms of resistance.
Financial relationships
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:AstrazenecaTopic:PARPiDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:MerckTopic:PARPiDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Daiichi-SankyoTopic:Antibody-drug conjugatesDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:NovartisTopic:CDK4/6iDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Illumina/GrailTopic:DNA sequencingDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:CARISTopic:DNA sequencingDate added:11/11/2023Date updated:11/11/2023
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Foundation MedicineTopic:DNA sequencingDate added:11/11/2023Date updated:11/11/2023